DE2064092C2
(de)
|
1970-12-28 |
1983-06-01 |
Bayer Ag, 5090 Leverkusen |
Inhibitoren für Glykosidhydrolasen aus Actinomyceten
|
US3937817A
(en)
|
1973-02-28 |
1976-02-10 |
Bayer Aktiengesellschaft |
Pharmaceutical compositions containing a saccharase inhibitor
|
US4016260A
(en)
|
1974-07-22 |
1977-04-05 |
Toyama Chemical Co., Ltd. |
Novel polypeptide produced by pseudomonas
|
FR2474829B1
(fr)
|
1980-02-01 |
1983-09-09 |
Agronomique Inst Nat Rech |
Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
|
FR2474828B1
(fr)
|
1980-02-01 |
1983-09-09 |
Agronomique Inst Nat Rech |
Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
|
US4491589A
(en)
|
1982-05-17 |
1985-01-01 |
The Trustees Of Columbia University In The City Of New York |
Amino acid solutions for parenteral nutrition and methods of formulation and use
|
DK589785A
(da)
|
1985-12-18 |
1987-06-19 |
Samuelsson Ernst Gunnar |
Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
|
IT1190349B
(it)
|
1986-06-16 |
1988-02-16 |
Prodotti Formenti Srl |
Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
|
FR2608050B1
(fr)
|
1986-12-15 |
1990-04-13 |
Bellon Labor Sa Roger |
Procede de preparation d'un melange peptidique riche en di- et tri-peptides, utilisable notamment en nutrition artificielle et en dietetique, melange ainsi obtenu, et utilisation de ce melange en nutrition artificielle et en dietetique
|
US5230902A
(en)
|
1988-04-29 |
1993-07-27 |
Immunotec Research Corporation |
Undenatured whey protein concentrate to improve active systemic humoral immune response
|
US5102871A
(en)
|
1989-04-24 |
1992-04-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Nutrient composition
|
FI904074A0
(fi)
|
1989-08-28 |
1990-08-17 |
Milupa Ag |
Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk.
|
US5407957A
(en)
|
1990-02-13 |
1995-04-18 |
Martek Corporation |
Production of docosahexaenoic acid by dinoflagellates
|
PH30997A
(en)
|
1990-03-12 |
1997-12-23 |
Ciba Geigy |
Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
|
DE69231793T2
(de)
|
1991-01-24 |
2001-11-08 |
Martek Corp., Columbia |
Mikrobielle öle und ihre verwendungen
|
US5308832A
(en)
|
1992-07-27 |
1994-05-03 |
Abbott Laboratories |
Nutritional product for persons having a neurological injury
|
GB9310472D0
(en)
|
1993-05-20 |
1993-07-07 |
Univ Warwick |
Phenylalanine-free protein and dna coding thereof
|
GB9312369D0
(en)
|
1993-06-16 |
1993-07-28 |
Sandoz Nutrition Ltd |
Organic compounds
|
US5405637A
(en)
|
1993-06-30 |
1995-04-11 |
Bristol-Myers Squibb Company |
Milk protein partial hydrolysate and infant formula containing same
|
US5723446A
(en)
|
1993-12-23 |
1998-03-03 |
Nestec Ltd. |
Enteral formulation designed for optimized nutrient absorption and wound healing
|
US5714472A
(en)
|
1993-12-23 |
1998-02-03 |
Nestec Ltd. |
Enternal formulation designed for optimized nutrient absorption and wound healing
|
US5605893A
(en)
|
1994-03-15 |
1997-02-25 |
Children's Hospital Of Los Angeles |
Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
|
US5643880A
(en)
|
1994-05-26 |
1997-07-01 |
Abbott Laboratories |
Product for inhibition of attachment of H. influenzae to human cells
|
AU691362B2
(en)
|
1994-11-04 |
1998-05-14 |
New Zealand Dairy Board |
Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
|
US5821217A
(en)
|
1995-10-27 |
1998-10-13 |
Beth Israel Deaconess Medical Center, Inc. |
Enteral formulation: low in fat and containing protein hydrolysates
|
IT1277964B1
(it)
|
1995-12-27 |
1997-11-12 |
Biosistema Di Pier Luigi Spara |
Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso
|
KR100194074B1
(ko)
|
1996-02-21 |
1999-06-15 |
박종헌 |
글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제
|
EP0912181A1
(en)
|
1996-07-17 |
1999-05-06 |
Nutracorp Scientific, Inc. |
Appetite suppression
|
KR100221124B1
(ko)
|
1996-09-23 |
1999-10-01 |
한상기 |
신규한 카제인 및 그 제조방법
|
NL1005037C2
(nl)
|
1997-01-17 |
1998-07-20 |
Nl Zuivelonderzoek Inst |
Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten.
|
CA2340223A1
(en)
|
1998-08-12 |
2000-02-24 |
Morinaga Milk Industry Co., Ltd. |
Nutritional compositions for preventing or treating hyperlipoproteinemia
|
US6077558A
(en)
|
1998-12-23 |
2000-06-20 |
Bristol-Myers Squibb Company |
Elemental nutritional products
|
US6905702B1
(en)
|
1999-11-08 |
2005-06-14 |
Children's Hospital Los Angeles |
Methods for regulating blood glucose and appetite suppression in type 2 diabetics
|
GB9927603D0
(en)
|
1999-11-22 |
2000-01-19 |
Nestle Sa |
Use of a milk protein hydrolysate in the treatment of diabetes
|
DE69930464D1
(de)
|
1999-12-30 |
2006-05-11 |
Kerry Group Services Ltd |
Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung
|
NL1014380C2
(nl)
|
2000-02-14 |
2001-08-15 |
Friesland Brands Bv |
Darmwandversterkend voedingsmiddel.
|
US6207638B1
(en)
|
2000-02-23 |
2001-03-27 |
Pacifichealth Laboratories, Inc. |
Nutritional intervention composition for enhancing and extending satiety
|
US7666996B2
(en)
|
2000-03-01 |
2010-02-23 |
Peptera Pharmaceuticals Ltd |
Casein derived peptides and uses thereof
|
IL134830A0
(en)
|
2000-03-01 |
2001-05-20 |
Chay 13 Medical Res Group N V |
Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
|
TWI268138B
(en)
|
2000-05-11 |
2006-12-11 |
Kanebo Seiyaku Ltd |
Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same
|
DE60127675T2
(de)
|
2000-06-28 |
2007-12-27 |
Fuji Nihon Seito Corp. |
Neuartige insulin synthase und verfahren zur herstellung von insulin durch anwendung derselben
|
GB0016189D0
(en)
|
2000-06-30 |
2000-08-23 |
Pepsyn Ltd |
Cosmetic composition
|
WO2002019832A1
(en)
|
2000-09-08 |
2002-03-14 |
New Zealand Dairy Board |
MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS
|
AU1142001A
(en)
|
2000-10-19 |
2002-04-29 |
Dsm N.V. |
Protein hydrolysates
|
AU2002320407A1
(en)
|
2001-07-10 |
2003-01-29 |
Trustees Of Boston University |
Modified-fat nutritional products useful for preventing or treating obesity
|
AU2002325890B2
(en)
|
2001-07-18 |
2007-10-04 |
Dsm Ip Assets B.V. |
Process for the hydrolysis of milk proteins
|
DE10149668A1
(de)
|
2001-10-09 |
2003-04-10 |
Numico Res B V |
Insulinmimetische Aminosäuresequenzen
|
JP2003137804A
(ja)
|
2001-10-31 |
2003-05-14 |
Morinaga Milk Ind Co Ltd |
インターロイキン−18誘導剤
|
DE60218064T2
(de)
|
2001-11-21 |
2007-11-15 |
Morinaga Milk Industry Co. Ltd. |
Neues peptid mit angiotensinkonvertase hemmender wirkung
|
EP1359157A1
(en)
|
2002-04-29 |
2003-11-05 |
Société des Produits Nestlé S.A. |
Metallo-proteinase inhibitory agent
|
US7460960B2
(en)
|
2002-05-10 |
2008-12-02 |
Epitome Biosystems, Inc. |
Proteome epitope tags and methods of use thereof in protein modification analysis
|
JP4376180B2
(ja)
|
2002-06-04 |
2009-12-02 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
トリペプチドに富むタンパク水解物
|
FR2841473B1
(fr)
|
2002-06-27 |
2004-09-17 |
Ingredia |
Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires
|
JP4719465B2
(ja)
|
2002-09-04 |
2011-07-06 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
インスリン感受性増強剤およびペプチド画分を含む栄養補給用および治療用組成物
|
TWI317636B
(en)
|
2002-11-22 |
2009-12-01 |
Meiji Dairies Corp |
Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
|
US20050148504A1
(en)
|
2002-11-29 |
2005-07-07 |
Nobuhiko Katunuma |
Cysteine protease inhibitor
|
ATE490323T1
(de)
|
2002-12-29 |
2010-12-15 |
Toudai Tlo Ltd |
Adiponektin-rezeptor und dafür kodierendes gen
|
US7785824B2
(en)
|
2003-05-05 |
2010-08-31 |
Conopco Inc. |
Hydrolysed casein product comprising tripeptides IPP and/or VPP
|
US8524225B2
(en)
|
2003-09-23 |
2013-09-03 |
Dsm Ip Assets B.V. |
Use of proline specific endoproteases to hydrolyse peptides and proteins
|
SG152271A1
(en)
|
2003-10-24 |
2009-05-29 |
Nutricia Nv |
Immunemodulating oligosaccharides
|
BE1015863A6
(nl)
|
2004-01-19 |
2005-10-04 |
Huybrechts Lucas |
Anticariogene proteinen & peptiden & sacchariden.
|
AU2005207891B2
(en)
|
2004-01-28 |
2010-04-01 |
Andromeda Biotech Ltd. |
Hsp therapy in conjunction with a low antigenicity diet
|
EP1568707A1
(en)
|
2004-02-26 |
2005-08-31 |
Puleva Biotech, S.A. |
Antihypertensive peptides from casein hydrolysates
|
BRPI0507822A
(pt)
|
2004-03-01 |
2007-07-10 |
Peptera Pharmaceuticals Ltd |
método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna
|
WO2005117933A1
(en)
|
2004-05-27 |
2005-12-15 |
Campina Nederland Holding B.V. |
Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition
|
US8252769B2
(en)
*
|
2004-06-22 |
2012-08-28 |
N. V. Nutricia |
Intestinal barrier integrity
|
DE102004040452A1
(de)
|
2004-08-20 |
2006-02-23 |
N.V. Nutricia |
Peptidgemisch
|
KR100560127B1
(ko)
|
2004-09-04 |
2006-03-13 |
한국기초과학지원연구원 |
인산화 단백질 분석용 겔-내 표지화 및 겔-내 단리 방법및 이를 이용한 단백질의 인산화 위치 동정 방법
|
JP5069121B2
(ja)
|
2004-11-12 |
2012-11-07 |
エヌ.ブイ.・ヌートリシア |
炎症反応を急激に軽減させる食品組成物
|
US8273710B2
(en)
|
2004-12-23 |
2012-09-25 |
Campina Nederland Holding B.V. |
Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
|
EA012300B1
(ru)
|
2005-01-18 |
2009-08-28 |
ДСМ АйПи АССЕТС Б.В. |
Композиция для лечения или предотвращения сахарного диабета и ее применение
|
ES2337495T3
(es)
|
2005-02-03 |
2010-04-26 |
Dsm Ip Assets B.V. |
Composiciones que comprenden galato de epigalocatecina e hidrolizado de proteina.
|
PT1845797E
(pt)
|
2005-02-09 |
2009-05-25 |
Unilever Nv |
Produtos alimentares compreendendo sólidos de leite hidrolisado com sabor melhorado
|
EP1874140B1
(en)
|
2005-04-28 |
2011-02-09 |
Unilever N.V. |
Peptides having a health benefit and compositions comprising them
|
AU2006239367A1
(en)
|
2005-04-28 |
2006-11-02 |
Dsm Ip Assets B.V. |
Novel nutraceutical compositions
|
WO2006118459A1
(en)
|
2005-04-29 |
2006-11-09 |
Campina Nederland Holding B.V. |
Antiviral peptides
|
ES2319475B1
(es)
|
2005-06-08 |
2010-02-16 |
Consejo Superior Investig. Cientificas |
Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
|
CN101212911B
(zh)
|
2005-07-01 |
2012-12-05 |
努特里希亚公司 |
含水解的蛋白质的婴儿营养品
|
GB0523806D0
(en)
|
2005-11-23 |
2006-01-04 |
Micromass Ltd |
Mass spectrometer
|
TW200803751A
(en)
|
2005-11-30 |
2008-01-16 |
Campina Nederland Holding Bv |
Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1
|
WO2008054192A1
(en)
|
2006-11-02 |
2008-05-08 |
N.V. Nutricia |
Use of nutritional compositions for preventing disorders
|
DK1800675T3
(da)
|
2005-12-23 |
2011-09-05 |
Nutricia Nv |
Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
|
EP1992354B1
(en)
|
2006-02-09 |
2014-04-09 |
Calpis Co., Ltd. |
Rheumatoid arthritis-preventive agent for oral intake
|
EP2007792A2
(en)
|
2006-03-22 |
2008-12-31 |
DSMIP Assets B.V. |
Cholesterol lowering protein hydrolysates
|
US20090305945A1
(en)
|
2006-04-12 |
2009-12-10 |
Swen Wolfram |
Novel nutraceutical compositions
|
JP5645360B2
(ja)
|
2006-04-21 |
2014-12-24 |
株式会社明治 |
ジペプチドを有効成分として含有する組成物
|
WO2007125946A1
(ja)
|
2006-04-28 |
2007-11-08 |
Snow Brand Milk Products Co., Ltd. |
ペプチド
|
KR20080003637A
(ko)
|
2006-07-03 |
2008-01-08 |
한상기 |
다이어트효과가 우수한 기능성 유산균발효조성물
|
BRPI0721827B8
(pt)
|
2006-08-04 |
2021-05-25 |
Shs Int Ltd |
uso de uma composição, e, composição
|
CN101500549A
(zh)
|
2006-08-09 |
2009-08-05 |
帝斯曼知识产权资产管理有限公司 |
酪蛋白复合物
|
NL1032840C2
(nl)
|
2006-11-09 |
2008-05-13 |
Friesland Brands Bv |
Probiotische hydrolysaatvoeding voor kinderen.
|
NL1033521C2
(nl)
|
2007-03-08 |
2008-09-09 |
Friesland Brands Bv |
Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
|
CN101547706B
(zh)
|
2007-04-12 |
2013-07-10 |
延世大学校产学协力团 |
包含含锌磁性金属氧化物纳米颗粒的磁共振成像造影剂
|
WO2008143954A2
(en)
|
2007-05-14 |
2008-11-27 |
Biogen Idec Ma Inc. |
Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
|
WO2008147562A2
(en)
|
2007-05-25 |
2008-12-04 |
Childrens's Medical Center Corporation |
Dietary formulations and methods for treatment of inflammation and other disorders
|
WO2008153429A2
(en)
|
2007-06-11 |
2008-12-18 |
Uniwersytet Jagiellonski |
A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use
|
KR20100058557A
(ko)
|
2007-09-11 |
2010-06-03 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 글루텐 엑소핀 c의 용도
|
WO2009054435A1
(ja)
|
2007-10-24 |
2009-04-30 |
Otsuka Chemical Co., Ltd. |
増強されたエフェクター機能を有するポリペプチド
|
US20110097437A1
(en)
*
|
2008-06-13 |
2011-04-28 |
N.V. Nutricia |
Nutrition for prevention of infections
|
US8859210B2
(en)
|
2008-10-17 |
2014-10-14 |
Mead Johnson Nutrition Company |
Method for identifying allergenic proteins and peptides
|
JP5735734B2
(ja)
|
2009-04-16 |
2015-06-17 |
雪印メグミルク株式会社 |
脂質代謝改善剤
|
EP2253324A1
(en)
|
2009-04-30 |
2010-11-24 |
Consejo Superior De Investigaciones Cientificas |
Use of a casein-derived peptide and compositions thereof as antihypertensive
|
EP2295535A1
(en)
|
2009-09-11 |
2011-03-16 |
Mead Johnson Nutrition Company |
Probiotic material
|
PL2332428T3
(pl)
|
2009-12-04 |
2015-02-27 |
Mjn Us Holdings Llc |
Formulacja odżywcza zawierająca hydrolizat zawierający peptydy mleka krowiego i/lub pochodzące z niego peptydy do indukowania tolerancji
|
DK2525811T4
(en)
|
2010-01-19 |
2019-04-08 |
Abbott Lab |
COMPOSITION, INCLUDING LACTOBACILLUS RHAMNOSUS HN001 AND PREBIOTICS FOR USE IN TREATMENT OF ALLERGIC LUNG DISEASE
|
AU2011221270A1
(en)
|
2010-02-24 |
2012-09-13 |
Morinaga Milk Industry Co.,Ltd. |
Therapeutic agent for eating disorders
|
WO2012092156A1
(en)
*
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
|
EP2514435A1
(en)
|
2011-04-19 |
2012-10-24 |
Nestec S.A. |
Infant formula for use in the prevention of cardiovascular diseases
|